Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.73
+0.24 (1.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Immunome Market Cap
Immunome has a market cap or net worth of $2.68 billion as of April 28, 2026. Its market cap has increased by 397.99% in one year.
Market Cap
2.68B
Enterprise Value
1.98B
1-Year Change
397.99%
Ranking
Category
Stock Price
$23.73
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.68B, an increase of 2,310.12%. That is a compound annual growth rate of 77.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 2.77B |
| Soleno Therapeutics | 2.73B |
| Beam Therapeutics | 2.72B |
| Vera Therapeutics | 2.70B |
| IDEAYA Biosciences | 2.70B |
| Enliven Therapeutics | 2.65B |
| Disc Medicine | 2.63B |
| ADMA Biologics | 2.62B |